ABBOTT LABORATORIES — Director's Dealing 2021

Dec 21, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2021-12-17

Reporting Person: Morrone Louis H. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-17	Common shares without par value	M	9988	$48.34	Acquired	48217	Direct
2021-12-17	Common shares without par value	S	9988	$137.54	Disposed	38229	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-17	Option (right to buy)	$48.34	M	9988	Disposed	2027-07-09	Common Shares (9988)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	2299	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of December 17, 2021.

F2: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.